X
Apr 12, 2021 03:38 PM (GMT+8) · EqualOcean
Onquality pharmaceuticals has recently completed a $20 million round of a + financing. The new shareholders in this round are Shiyu capital, Innovation workshop and other individual investors, while the old shareholders Jingwei China, Boyuan capital, Fengrui capital and guokejiahe continue to add weight. The accumulated US $35 million of financing obtained by the a round and a + round of ankuo pharmaceutical will be used to support the multi center phase II clinical trials being carried out by ankuo pharmaceutical in the United States, as well as the research and development of the following four projects to carry out clinical trials in the next 18 months.